Assistant Professor, Pediatrics, University of Alabama School of Medicine
Pediatric Rheumatology
Dr. Timothy G. Beukelman, MD
|
|
Give Review
Timothy Beukelman practices Pediatric Rheumatology. He went to Washington University School of Medicine in St. Louis. He received awards:"Fellow (FACR)" and "Fellow". Doctor Timothy G. Beukelman, MD is also a published MD. He has 59 publication published. The most recent publication is: A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.
Publications
- A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.
- Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathi...
- Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin ...
- Safety and Efficacy of Rituximab in Childhood-onset Systemic Lupus Erythematosus and Other Rheumatic Diseases.
- Development and retrospective validation of the juvenile spondyloArthritis disease activity index.
- Impact of biologics with and without concomitant MTX and at reduced doses in older rheumatoid Arthritis patients.
- Recent trends in medication usage for the treatment of juvenile idiopathic Arthritis and the influence of tumor necrosis factor inhibitors.
- Risks of Herpes Zoster in Patients with Rheumatoid Arthritis According to Biologic Disease Modifying Therapy.
- Risk of malignancy associated with biologic agents in pediatric rheumatic Disease.
- Adding canakinumab to the childhood Arthritis and rheumatology research alliance consensus treatment plans for systemic juvenile idiopathic Arthritis.
- A44: High Levels of DEK Autoantibodies May Predict Early Flare Following Cessation of Anti-TNF Therapy.
- Risk of hospitalised infection in rheumatoid Arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.
- Changes in Body Mass Index in Children with Juvenile Idiopathic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
- Using Registries to Identify Adverse Events in Rheumatic Diseases.
- 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of...
- Imaging of the temporomandibular joint in juvenile idiopathic Arthritis.
- High Doses of Infliximab in the Management of Juvenile Idiopathic Arthritis.
- Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study.
- Infectious complications in juvenile idiopathic Arthritis.
- Race, Ethnicity, and Disease Outcomes in Juvenile Idiopathic Arthritis: A Cross-sectional Analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA...
- Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
- Incidence of selected opportunistic infections among children with juvenile idiopathic Arthritis.
- What is the Background Incidence of Malignancy in Children with Rheumatic Disease?
- Tumor necrosis factor ? inhibitor therapy and cancer risk in Chronic immune-mediated diseases.
- Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study.
- Enthesitis-related Arthritis Is Associated with Higher Pain Intensity and Poorer Health Status in Comparison with Other Categories of Juvenile Idiopathic Arthritis: Th...
- Disease-modifying Antirheumatic Drug Use in the Treatment of Juvenile Idiopathic Arthritis: A Cross-sectional Analysis of the CARRA Registry.
- Rates of hospitalized bacterial infection associated with juvenile idiopathic Arthritis and its treatment.
- Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States.
- Risk Factors for Temporomandibular Joint Arthritis in Children with Juvenile Idiopathic Arthritis.
- 2012 update of the 2008 american college of rheumatology recommendations for the use of Disease-modifying antirheumatic drugs and biologic agents in the treatment of r...
- Rates of malignancy associated with juvenile idiopathic Arthritis and its treatment.
- Incidence and risk factors for Progressive Multifocal Leukoencephalopathy among patients with selected rheumatic Diseases.
- Treatment advances in systemic juvenile idiopathic Arthritis.
- Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic Arthritis: enthesitis-related Arthritis predicts persiste...
- Initiation of Tumor Necrosis Factor-? Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases.
- Temporomandibular joint Arthritis in pediatric sjogren disease and sarcoidosis.
- Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.
- Geographic Distribution of Endemic Fungal Infections among Older Persons, United States.
- Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjogren's syndrome.
- High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort.
- The comparative risk of serious infections among rheumatoid Arthritis patients starting or switching biological agents.
- 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic Arthritis: initiation and safety monitoring of therapeutic agents for th...
- Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic Arthritis: a retrospective case series.
- Measuring process of Arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic Arthritis.
- Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
- Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell ...
- Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis.
- Rituximab therapy for severe refractory Chronic Henoch-Schönlein purpura.
- Elevated liver enzyme tests among patients with rheumatoid Arthritis or psoriatic Arthritis treated with methotrexate and/or leflunomide.
- Optimal treatment of knee monArthritis in juvenile idiopathic Arthritis: a decision analysis.
- Usage of intra-articular corticosteroid injections for the treatment of juvenile idiopathic Arthritis: a survey of pediatric rheumatologists in the United States and C...
- Evaluation of the presentation of systemic onset juvenile rheumatoid Arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR).
- Variation in the initial treatment of knee monoArthritis in juvenile idiopathic Arthritis: a survey of pediatric rheumatologists in the United States and Canada.
- Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar Arthritis in juvenile idiopathic Arthritis.
- Occult macrophage activation syndrome in patients with systemic juvenile idiopathic Arthritis.
- Juvenile idiopathic Arthritis classification criteria: loopholes and diagnosis software.
- Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar Arthritis in juvenile idiopathic Arthritis.
Schools
Washington Center School of Medicine
Procedures Preformed
- Joint Drainage
Conditions Treated
- Arthritis
- Dermatomyositis
- Juvenile Chronic Arthritis
- Rheumatoid Arthritis
- View All
Doctors Specialties
- Pediatric Rheumatology
Accepted Insurances
Awards
- Fellow (FACR)
- Fellow
Education
-
Children's Hospital of Philadelphia -
Cincinnati Children's Hospital Medical Center -
Washington University School of Medicine in St. Louis
Hospital
-
University of Alabama Hospital
Helpful Reviews
Similar Doctors
|
Dr. Robert M. Lowe, MD |
|
|
Dr. Peter Weiser, MD |
|
|
Dr. Matthew L. Stoll, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren E. Shipman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randall Q. Cron, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Brandon J. Dorion, MD
This Doctor is OpenDoctor Recommended.
|